F072 - The Big C's: Children, Cancer, and Cutaneous Complications
Saturday, February 17; 1:00 PM - 3:00 PM
Following this course, the attendee should be able to:
- Distinguish pediatric from adult clinical presentation and outcome in cutaneous T cell lymphoma.
- Diagnose and manage concerning melanocytic lesions in children.
- Develop an approach to cutaneous mastocytosis in children.
Dermatologists can be useful and important in the management of pediatric oncology patients. This session will highlight important cutaneous malignancies and other proliferative disorders in children. Topics will include pediatric melanoma, cutaneous T cell lymphoma, cutaneous mastocytosis, and secondary skin cancer in childhood cancer survivors. This session is geared towards any practitioner interested in honing their approach to the diagnosis and management of children with cutaneous malignancies.
- Coughlin, Carrie C., MD: no financial relationships exist with commercial interests.
- Guitart, Joan, MD: Actelion – I(Grants/Research Funding); Elorac, Inc. – I(Grants/Research Funding); Galderma Research & Development, LLC – I(Grants/Research Funding); LEO Laboratories Ltd (LEO Pharma) – A(Fees); miRagen Therapeutics, Inc. – I(Grants/Research Funding); Soligenix, Inc – I(Grants/Research Funding);
- Hawryluk, Elena B., MD, PhD: Gritstone Oncology – E(S); UpToDate, Inc – O(OB);
- Huang, Jennifer T., MD: no financial relationships exist with commercial interests.
- Maguiness, Sheilagh M., MD: Regeneron Pharmaceuticals, Inc. – A(H);
- Miller, Daniel D., MD: JAMA – E(H); UpToDate, Inc – O(H);
- Smidt, Aimee, MD: no financial relationships exist with commercial interests.
Saturday, February 17
Dr. Hawryluk / Pediatric melanoma update
Dr. Guitart / Diagnosis and management of CTCL in children
Dr. Maguiness and Dr. Miller / CPC: Malignancy or not?
Dr. Smidt / A practical approach to cutaneous mastocytosis in children
Dr. Coughlin / Skin cancer surveillance after cancer therapy: When to worry